Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 히다까 히로요시filedCritical히다까 히로요시
Priority to KR1019820004498ApriorityCriticalpatent/KR840001973A/en
Publication of KR840001973ApublicationCriticalpatent/KR840001973A/en
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.
Claims (2)
하기 일반식(2)로 표시되는 3-[4-(벤조일알킬)피페라진-1-일]시드논이민 화합물을 하기 일반식(3)으로 표시되는 카르복실산 또는 그의 반응성 유도체와 반응시킴을 특징으로 하는 하기 일반식(1)로 표시되는 N-아실-3-[4-(벤조일알킬)피페라진-1-일]시드논이민 화합물의 제조방법.Reacting a 3- [4- (benzoylalkyl) piperazin-1-yl] sidonimine compound represented by the following general formula (2) with a carboxylic acid represented by the following general formula (3) or a reactive derivative thereof A process for producing an N-acyl-3- [4- (benzoylalkyl) piperazin-1-yl] sidonimine compound represented by the following General Formula (1).상기 식에서, R1은 수소원자 또는 탄소원자수 1 내지 8의 알킬기를 나타내고, R2는 저급알킬기, 저급알콕시기 또는 페닐기를 나타내고,은 0 또는 1~10의 정수를 나타낸다.Wherein R 1 represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, R 2 represents a lower alkyl group, a lower alkoxy group or a phenyl group, Represents the integer of 0 or 1-10.제1항에 있어서, 하기 일반식(4)의 4-(벤조일알킬)-1-(N-니트로소시아노메틸아미노)피페라진을 산과 접촉시킴으로써 하기 일반식(2)의 화합물을 제조하는 방법.The process according to claim 1, wherein the compound of formula (2) is prepared by contacting 4- (benzoylalkyl) -1- (N-nitrosocyanomethylamino) piperazine of formula (4) with an acid.상기 식에서, R1은 수소원자 또는 탄소원자수 1 내지 8의 알킬기를 나타내고,은 0 또는 1~10의 정수를 나타낸다.In the above formula, R 1 represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, Represents the integer of 0 or 1-10.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
Cradrate compound, manufacturing method thereof, and coating composition containing same (Novel Clathrate Compound, Process for Producing the Same and Coating Composition Containing Said Novel Clathrate Compound)